Appeal No. 1996-2209
Application No. 08/031,346
oxidant with a member selected from the group consisting of ozone, oxygen, UV radiation and
mixtures thereof;
recombining the treated first fraction and the treated second fraction.
26. A process for the production of germicidally treated suspensions comprising
withdrawing blood from a person suffering from a member of the group of illnesses consisting
of atopic neurodermatitis, bronchial asthma and nasal allergies, allergies, colitis ulcerosa,
Parkinson, Morbus Crohn, Hepatitis, chronic Hepatitis, chronic Sinusitis, Psoriasis, rheumatic-
type indications, carcinomas, multiple sclerosis, and scleroderma Sjögren syndrome and
combinations thereof;
treating said blood with an oxidant;
centrifuging the erythrocytes out of said blood thereby removing plasma from the
centrifuged erythrocytes;
treating the plasma with an oxidant;
treating the centrifuged erythrocytes with an oxidant;
partially suspending the oxidized erythrocytes in distilled water so as to burst these
erythrocytes through osmosis;
treating a urine filtrate with oxidant;
adding the oxidized urine filtrate to the oxidized plasma;
combining the fraction containing the erythrocytes and the fraction containing the
plasma and the urine filtrate for generating a combined suspension;
contacting an immune system with the combined suspension for modulating the
immune-active properties of the immune system.
The prior art references relied upon by the examiner are:
Zee et al. (Zee) 4,632,980 Dec. 30, 1986
3
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next
Last modified: November 3, 2007